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Objective: Hormone secretion from metabolically active tissues, such as pancreatic islets, is governed by specific and highly regulated signaling
pathways. Defects in insulin secretion are among the major causes of diabetes. The molecular mechanisms underlying regulated insulin secretion
are, however, not yet completely understood. In this work, we studied the role of the GTPase ARFRP1 on insulin secretion from pancreatic b-cells.
Methods: A b-cell-specific Arfrp1 knockout mouse was phenotypically characterized. Pulldown experiments and mass spectrometry analysis
were employed to screen for new ARFRP1-interacting proteins. Co-immunoprecipitation assays as well as super-resolution microscopy were
applied for validation.
Results: The GTPase ARFRP1 interacts with the Golgi-associated PDZ and coiled-coil motif-containing protein (GOPC). Both proteins are co-
localized at the trans-Golgi network and regulate the first and second phase of insulin secretion by controlling the plasma membrane locali-
zation of the SNARE protein SNAP25. Downregulation of both GOPC and ARFRP1 in Min6 cells interferes with the plasma membrane localization of
SNAP25 and enhances its degradation, thereby impairing glucose-stimulated insulin release from b-cells. In turn, overexpression of SNAP25 as
well as GOPC restores insulin secretion in islets from b-cell-specific Arfrp1 knockout mice.
Conclusion: Our results identify a hitherto unrecognized pathway required for insulin secretion at the level of trans-Golgi sorting.
 2020 The Authors. Published by Elsevier GmbH. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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Insulin secretion from pancreatic b-cells is a highly dynamic and
regulated process that is essential for maintaining glucose homeo-
stasis. Insufficient insulin release results in metabolic disorders that
lead to type 2 diabetes (T2D). Genome-wide association studies
(GWAS) often connect single-nucleotide polymorphisms (SNPs) in
genes required for protein secretion in diabetes [1,2]. However,
mechanistic insights that support these studies are still sparse.
In the postprandial state, dietary glucose from the circulation enters b-
cells via the glucose transporter GLUT1 in humans and GLUT2 in ro-
dents and is immediately metabolized [3,4]. ATP-sensitive potassium
channels in the plasma membrane are closed due to a rising ATP:ADP
ratio, leading to membrane depolarization, followed by opening of
voltage-dependent Ca2þ channels [5e7]. Increasing Ca2þ concen-
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containing granules with the plasma membrane via SNARE-complex
formation, followed by the release of insulin into the extracellular
space [8]. A well-studied SNARE complex in this context consists of
VAMP2, Syntaxin1A, and SNAP25 that assemble in a 1:1:1 stoichi-
ometry [9,10]. However, other SNARE proteins, such as Syntaxin4, are
also implicated in the process of biphasic insulin secretion [11,12].
Insulin is secreted in two distinct phases: the first and acute phase is
mediated by a pool of pre-docked insulin-containing granules [13]. The
ensuing second phase, which is longer lasting but weaker, may be
mediated by a pool of storage granules [14]. This finding, however, is
highly debated. More recent research suggests that the second phase
is instead governed by so-called newcomer granules [15].
Like many other membrane trafficking steps within the secretory
pathway, the different stages in the lifetime of insulin granules,
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formation about the individual steps is still missing. ARFRP1 is a small
monomeric GTPase of the ARF family [16]. It is found at the trans-Golgi
network in its active GTP-bound state. ARF family members are key
regulators of cellular signaling processes as nearly every trafficking
step to or from the Golgi is described to be regulated by at least one
GTPase of the ARF or Rab family [17,18]. Arfrp1 is ubiquitously
expressed. As suggested by different conditional knockout studies, it
plays a pivotal role in glucose and lipid metabolism [19e21]. ARFRP1
is also involved in post-Golgi trafficking to the plasma membrane. For
example, the plasma membrane trafficking of vesicular stomatitis virus
glycoprotein (VSVG) and of VANGL2 in polarized cells depends on
ARFRP1 [22,23]. ARFRP1 is required for the recruitment of ARL1 and
its effectors, the scaffolding proteins Golgin-97 and Golgin-245, to the
trans-Golgi network [24e26]. Our recent work suggests that ARFRP1
is required for hormone release from metabolic active tissues [27]. We
therefore hypothesized that ARFRP1 is involved in the process of in-
sulin secretion from pancreatic b-cells. Phenotypic characterization of
b-cell-specific Arfrp1 knockout mice supports this hypothesis as these
mice have elevated blood glucose levels and a reduced capacity in
glucose-stimulated insulin secretion.
Here, by screening for potential ARFRP1-interacting proteins, we
identified the Golgi-associated PDZ and coiled-coil motif-containing
protein (GOPC). Functional assays revealed that this interaction is
necessary for correct localization of the t-SNARE protein SNAP25 at the
plasma membrane and thereby participates in the process of glucose-
stimulated insulin secretion from b-cells.
2. MATERIALS AND METHODS
2.1. Animals
To generate b-cell-specific Arfrp1 knockout mice with a C57BL/6J
background, Arfrp1flox/flox mice [28] were crossed with Ins1Cre mice
[29]. Animals were housed in a 22 2 C environment with a 12:12-h
light:dark cycle and unlimited access to food and water. Body weight,
body composition (fatþ lean mass), blood glucose, and plasma insulin
levels were measured weekly from week 4 until week 14. At the age of
10 weeks, oral glucose tolerance tests were performed in male mice
after a 4-h fasting period. Glucose was orally applied at 2 mg/g body
weight. All metabolic measurements shown in the paper were per-
formed in male mice between the ages of 10 and 14 weeks. Female
mice showed the same effects on blood glucose and degradation of
SNAP25 and GOPC proteins. Use of female mice e.g., for immunos-
tainings or quantitative reverse transcription polymerase chain reaction
(qRT-PCR), is stated in the figure legends, respectively. All animal
experiments were approved by the ethics committee of the State Office
of Environment, Health, and Consumer Protection (Federal State of
Brandenburg, Germany).
2.2. Mass spec and LUMIER
Human ARFRP1 (Uniprot-ID Q13795) was expressed as a GST-fusion
protein from pGEX-6P1 in E. coli BL21(DE3). Cells were cultured at
37 C to an OD600 of 0.5, followed by 16 h of growth at 18 C after
addition of 100 mM of isopropyl-b-D-thiogalactopyranosid (IPTG). Cells
were disrupted with a fluidizer in buffer A (50 mM of HEPES, pH 7.5,
300 mM of NaCl, 2.5 mM of 2-mercaptoethanol, 2 mM of MgCl2).
Cleared lysates (96,000g, 30 min, 4 C) were loaded on a gluta-
thione sepharose column. Following extensive washing (buffer A with
500 mM of NaCl), protein was eluted (buffer A with 20 mM of gluta-
thione) and subjected to size exclusion chromatography in buffer B
(20 mM of HEPES, pH 7.5, 150 mM of NaCl, 2.5 mM of 2-2 MOLECULAR METABOLISM 45 (2021) 101151  2020 The Authors. Published by Elsevier GmbH. Tmercaptoethanol, and 2 mM of MgCl2). GST was expressed and pu-
rified from an unmodified pGEX-6P1 in an analogous way. Six nano-
moles of GST-ARFRP1 and a GST control were bound to glutathione
sepharose in buffer B. Bead-bound proteins were loaded with GTPgS
by 10 min of incubation with buffer B supplemented with 200 mM of
ammonium sulfate, 10 mM of EDTA, and 2 mM of GTPgS, followed by
a 10-min incubation in buffer B supplemented with 200 mM of
ammonium sulfate, 20 mM of MgCl2, and 2 mM of GTPgS. GST-
ARFRP1 could only partially be loaded with GTPgS with this proto-
col, as judged by high-performance liquid chromatography (HPLC)
analysis, and a substantial GDP fraction remained. Pulldowns were
therefore performed with GST-ARFRP1CGTPgS compared to GST
alone. Brains from two 4-week-old mice were homogenized in ice-cold
lysis buffer (50 mM of TriseHCL, pH 7.5, 150 mM of NaCl, 1.2% (w/v)
octyl glucoside, 1 mM of EDTA, 1 mM of EGTA, cOmplete protease
inhibitor (Roche)). Insoluble material was removed by 2  25-min
centrifugation at 16,100g at 4 C, and the soluble extract was
incubated with bead-bound GST-ARFRP1CGTPgS and GST for
30 min at 4 C. Beads were washed 3 times with buffer B, and retained
proteins were separated by sodium dodecyl sulfate polyacrylamide gel
electrophoresis (SDS-PAGE). Gel bands from the GST-ARFRP1 and GST
control pulldowns were excised and subjected to tryptic in-gel
digestion [30]. Samples were measured by liquid chromatography
tandem mass spectrometry (LC-MS/MS) on a Q Exactive Plus (Thermo)
and an Orbitrap Fusion mass spectrometer (Thermo) connected to an
EASY-nLC system (Thermo) as technical replicates. Database search
was performed with MaxQuant version 1.5.2.8 [31]. A spectral
counting approach was used to compare GST-ARFRP1 and GST control
samples. Protein groups were filtered for those containing at least 10
different peptide IDs with a total intensity of 108. The number of
peptide IDs in the GST-ARFRP1 pulldown samples was summed for
each protein group and divided by the total number of peptide IDs in
GST-ARFRP1 and GST control. Protein groups with a ratio of >0.9
were further refined to proteins with a known Golgi-localization
(GO:0005794) and/or involvement in vesicular trafficking
(GO:0016192).
From the remaining 23 mass spectrometry hits, 16 were further tested
in a modified LUMIER (luminescence-based mammalian interactome)
assay [32]. Briefly, a N-terminal protein A (PA)-Renilla luciferase (RL)-
ARFRP1 fusion protein (PA-RL-ARFRP1) was co-expressed with V5-
firefly luciferase (FL)-tagged prey proteins (V5-FL-prey) in HEK293
cells. After 48 h, cells were lysed in buffer C (1% NP40, 50 mM of
HEPES/NaOH pH 7.4, 150 mM of NaCl, 1.5 mM of MgCl2, 1 mM of
EDTA, 1 mM of DTT) with cOmplete protease inhibitors and Benzonase
(Merck). Protein complexes were captured using immunoglobulin G
(IgG, Jackson Immunoresearch) immobilized to high-binding 96-well
white plates (Greiner). Bound protein complexes were washed with
buffer C without NP40, and firefly luciferase activity was quantified
with the Dual-Glo Luciferase Assay System (Promega) using an Infinite
M200 reader (Tecan). Firefly activities were normalized to co-IP con-
trols, employing a PA-RL fusion protein as bait and firefly-V5-tagged
prey proteins. Co-IPs were performed in triplicate.
2.3. Cell culture and transfection
All cell lines were cultured at 37 C and 5% CO2. Min6 cells were
cultured in high-glucose Dulbecco’s modified Eagle’s medium (DMEM,
PAN) supplemented with 10% heat-inactivated fetal bovine serum
(FBS, Gibco). For adenoviral infection, 1.6 * 105 Min6 cells were
seeded per 24-well plate and 3.2 * 105 cells per 12-well plate. Cells
were infected with indicated multiplicities of infection (MOIs) and, if not
otherwise stated, harvested after 48 h. Ins1 cells were cultured inhis is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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RPMI (PAN) supplemented with 10% FCS (PAN), 1% HEPES (PAN),
2 mM of glutamine, 1 mM of Na-pyruvate, and 0.05 mM of 2-
mercaptoethanol (Sigma). For microscopy experiments, 1.2 * 105
cells were seeded on poly-L-lysine (Sigma) coated coverslips and
cultured for 48 h. Ins1 cells were preferred over Min6 for 3D-SIM
(structured illumination microscopy) since antibodies used within this
study worked better in this cell line. HeLa cells were cultured in Earles
medium (PAN) supplemented with 10% FCS (PAN). For co-IP experi-
ments, 1.8 * 105 cells were seeded per 6-well plate. To block lyso-
somal degradation, Min6 cells were treated with 10 mM of chloroquine
for 16 h. For determination of protein half-life, Min6 cells were incu-
bated for indicated time points with 100 mg/ml of cycloheximide. All
cell lines were regularly tested for contamination using the
VenorGeM Advance kit (Minerva).
2.4. Plasmids
ARFRP1-expressing constructs were described previously [24]. All
other constructs were purchased from Geneart (Thermo Fisher,
Regensburg), and adenoviral constructs were obtained from Vector
Biolabs (USA).
2.5. Western blotting and co-immunoprecipitation
Co-immunoprecipitations were performed using GFP-Traps (Chromo-
tek) according to the manufacturer’s protocol. Briefly, transfected HeLa
cells were lysed in ice-cold lysis buffer (10 mM of Tris/Cl pH 7.5,
150 mM of NaCl, 0.5 mM of EDTA, 0.5% NP40), and 3 wells were
pooled. Protein concentrations were determined in a BCA assay. Per
pulldown, 300 mg of lysate was filled up to 500 ml, and 10 ml of GFP-
traps were added. Samples were rotated overnight at 4 C, washed 3
times, and transferred to a new tube. Immunocomplexes were eluted
from beads in SDS-sample buffer by boiling for 10 min. Twenty mi-
croliters of eluate were run on an SDS-PAGE and transferred to
nitrocellulose membranes by tank-blotting. Membranes were incu-
bated with primary antibodies as indicated overnight at 4 C and
detected with the LICOR Odyssey system. Quantification of bands were
performed using Image Studio Lite software (Ver. 5.2).
2.6. Measurement of insulin secretion via perifusion
Isolation of pancreatic islets from 12- to14-week-old male mice was
performed as described [33] and recovered overnight. Thirty to 40
islets per mouse were equilibrated in KRBH buffer with low glucose
(2.8 mM) before transferring to chambers of a perifusion system (PERI-
4.2, Biorep). Glucose-stimulated insulin secretion (GSIS) was recorded
with a continues flow of 100 ml/min under indicated glucose con-
centrations over indicated time points. Islets were collected from beads
with acid ethanol (0.18 M of HCl in 70% ethanol) for determination of
residual insulin. Area under the curve (AUC) was calculated in
GraphPad Prism 8.1.2 for the 1st phase from 20 to 34 min and for the
2nd phase from 37 to 58 min.
2.7. GSIS
GSIS from Min6 cells was performed 48 h post adenoviral infection.
Cells were washed with KRBH buffer containing 2.8 mM of glucose and
equilibrated for 1 h. Glucose was added to a final concentration of
20 mM, and supernatants were collected after another 60 min. Su-
pernatants were subjected to enzyme-linked immunosorbent assay
(ELISA) experiments, and cells were lysed for DNA concentration
measurements using the Quant-IT PicoGreen Kit (Invitrogen). GSIS
from isolated islets was performed 48 h post adenoviral infection in a
12-well plate. Two times 10 islets per mouse were pre-incubated for
1 h in 1 ml of KRBH buffer containing 2.8 mM of glucose beforeMOLECULAR METABOLISM 45 (2021) 101151  2020 The Authors. Published by Elsevier GmbH. This is an open a
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pernatant was collected, representing basal insulin release, and islets
were transferred into KRBH buffer containing 20 mM of glucose for 1 h.
Afterwards, supernatant was collected, and islets were transferred into
200 ml of acidic ethanol for measuring residual insulin. Released in-
sulin was measured in duplicates and normalized to residual insulin.
2.8. Measurement of insulin concentration via ELISA
Insulin concentrations from GSIS in Min6 cells and isolated islets were
measured from supernatants with a mouse high range and ultrasen-
sitive insulin ELISA kit (Alpco) according to the manufacturer’s in-
struction and normalized to DNA concentration (ng/ml). Insulin
concentrations from perifusion experiments were measured with a
mouse ultrasensitive insulin ELISA kit (Alpco) according to the manu-
facturer’s instructions and normalized to residual insulin from islets.
2.9. Morphometric analysis of pancreatic sections
For determination of islet size and abundance, pancreas from 3 mice
per genotype were isolated, fixed, and embedded into paraffin blocks.
From each pancreas, 4-mm-thick sections were taken in triplicates
from the apical, mid, and distal parts of the organ. Sections were
deparaffinized and stained for insulin by DAB (3,30-diaminobenzidine)
labeling. After incubation with primary antibody for 1 h at room tem-
perature, sections were washed and incubated with peroxidase-
coupled secondary antibody (Histofine Simple Stain MAX PO anti
mouse) for 30 min. Sections were then incubated with substrate so-
lution (DakoCytomation Liquid DAB þ Substrate Chromogen System).
Images of the whole sections were recorded with a MIRAX MIDI
scanner (Zeiss) and analyzed using the MIRAX Viewer software.
2.10. Confocal microscopy and SIM
For microscopy experiments, cells were fixed for 10 min in 4%
paraformaldehyde (PFA) and washed 3 times in phosphate-buffered
saline (PBS). Cells were incubated 3 times in 50 mM of NH4Cl/PBS,
permeabilized for 6 min in 0.2% saponin/PBS, and incubated for 5 min
in 0.02% saponin/PBS. After blocking for 45 min in 2% bovine serum
albumin (BSA) in 0.02% saponin/PBS, cells were incubated with pri-
mary antibodies diluted in blocking buffer overnight at 4 C or 2 h at
room temperature (RT). Cells were washed 3 times and incubated for
1 h with secondary antibodies diluted in blocking buffer supplemented
with 40,6-diamidino-2-phenylindole (DAPI). Cells were mounted in
ProLong Glass Antifade Mountant und subjected to confocal or SIM
microscopy. Confocal microscopy was performed with a Leica TCS
SP8 microscope equipped with a white light laser and a 405 diode.
Fluorophores were excited at respective wavelength and sequential
scans for image collection performed with a 63x objective with a
numerical aperture of 1.4 using oil immersion, speed of 100 Hz and a
frame average of 4 at RT.
Three-dimensional (3D) 3-color SIM images were acquired using
488 nm, 568 nm, and 642 nm laser lines, standard filter sets, and
125-nm z-sectioning of the OMX V4 Blaze (GE Healthcare) system. One
hundred-nanometer fluorescent beads (Tetraspeck, T7284, Thermo
Fischer Scientific) were used for registration of individual channels,
achieving less than 40 nm registration, respectively. Image and movie
processing, including 3D-rendering was done using Arivis Vision4D.
Objects were identified in ImageJ with a histogram-based threshold
procedure (Otsu’s method) on the maximum projection of the 3D SIM
stack. Holes up to one pixel (40  40 nm) were closed. Only objects
with a surface area above 0.008 mm2 were considered as signals. In-
focus planes were automatically extracted from 3D-SIM stacks based
on their signal-to-noise ratio, using a custom-written ImageJ script.ccess article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/). 3
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objects with a volume larger than 0.0025 mm3 were included in the
analysis. Distances from surfaces of all possible combinations of ob-
jects were exported from Arivis Vision 4D and nearest neighbor (NN)
distances were calculated using a custom-written python script. The
same procedure was repeated after randomization by a toroidal shift of
3 mm. NN distances are displayed as mean of the “corrected NN
Distance”, which was calculated as the mean of all NN distances after
subtracting the distance from random object distributions.
2.11. RNA extraction and RT-qPCR
RNA extraction from freshly isolated islets was performed using the
Qiagen RNeasy MinElute Kit according to the manufacturer’s in-
structions. cDNA was generated using M-MLV (M3683) reverse tran-
scriptase from Promega. Gene expression of Arfrp1, Snap25 and
insulin was measured by RT-qPCR and normalized to housekeeping
genes Ppia and Eef2 using specific probes (Taqman and IDT).
2.12. Antibodies
Antibodies used within this study for Western blotting and stainings are
listed with their respective dilutions in Table 1.Table 1 e Antibodies used within this study.
Antibody Company Catalog number Application Dilution
a-Tubulin Sigma T 6074 WB (loading) 1:500
ARFRP1 Abcam ab108199 WB 1:500
ARFRP1-A647 Abcam ab108199 IF 1:300
EXOC7 Millipore MABT186 IF 1:100
GAPDH Ambion AM4300 WB (loading) 1:10,000
GFP Santa Cruz sc-9996 WB 1:500
Glucagon Santa Cruz sc-7779 IHC 1:50
GOPC Abcam
Insulin Sigma I 2018 IF/IHC 1:50,000
Myc-Tag Cell Signaling #2272 WB 1:1,000
PIST HJK / IF 1:1,000
SNAP25 BioLegend 836304 IF/WB 1:100/1:1,000
Syntaxin1 Sigma So664 WB 1:1000
VAMP2 Abcam ab3347 WB 1:1000
VPS35 Abcam ab57632 IF/WB 1:200/1:1,000
WB ¼ Western blot, IF ¼ immunofluorescence, IHC ¼ immunohistochemistry.3. RESULTS
3.1. ARFRP1 function in b-cells is required for correct insulin
secretion in mice
To characterize a possible role of ARFRP1 for insulin secretion, b-cell-
specific knockout mice (Arfrp1b-cell/) were generated. A mouse
strain with a floxed Arfrp1 allele (Arfrp1flox/flox) [28] was intercrossed
with mice expressing the Cre recombinase specifically in b-cells
(Ins1Cre mice) [29] (Appendix Fig. S1A). Knockout efficiency and
specificity were proven by qRT-PCR and Western blot analysis of islets
and different tissues (Figure 1A and Appendix Fig. S1BeD). Whereas
ARFRP1 expression was essentially not altered in most of the tested
tissues, it was greatly reduced in islets from Arfrp1b-cell/ mice
(Appendix Fig. S1C þ D, Figure 1A). The residual ARFRP1 signal may
stem from non-b-cells, such as a-cells that secrete the insulin-
counteracting peptide hormone glucagon. These cells are also abun-
dantly found in islets as they make up 15e20% of islet mass [34].
Supporting this assumption, immunostainings of isolated islets from
Arfrp1b-cell/mice showed a juxtanuclear staining for ARFRP1 (white)
in glucagon-positive a-cells (green) (Figure 1B).4 MOLECULAR METABOLISM 45 (2021) 101151  2020 The Authors. Published by Elsevier GmbH. TPhenotypic characterization of Arfrp1b-cell/ and control mice revealed
that deletion of Arfrp1 in b-cells led to elevated blood glucose
(Figure 1C). The measured glucose levels are, however, not high enough
to rank it glucotoxic [35]. Furthermore, GLUT2, which is downregulated
under glucotoxic conditions, was unaltered in islets of Arfrp1b-cell/
mice (Appendix Fig. S1N). Plasma insulin levels, as shown for 13-week-
old mice, were decreased in Arfrp1b-cell/ mice (Figure 1D). Total
pancreatic insulin levels as well as Ins2 expression, however, were not
significantly different between the two genotypes (Figure 1E and
Appendix Fig. S1E), nor was the body weight or body composition
(Appendix Fig. S1FeH). For body fat mass, higher values were observed
in Arfrp1b-cell/ mice, without reaching statistical significance.
Although fat mass was slightly increased in Arfrp1b-cell/ mice, leptin
levels were not different in the plasma of the two different mice strains
(2.1 0.4 ng/ml in Arfrp1flox/floxmice, 2.3 1.4 ng/ml in Arfrp1b-cell/
mice). Further measurements of immature pro-insulin and cleaved C-
peptide in pancreas from Arfrp1flox/flox and Arfrp1b-cell/ mice revealed
no differences, indicating that the reduced plasma insulin concentrations
of Arfrp1b-cell/ mice were not caused by an impaired maturation of
insulin (Appendix Fig. S1I and J). Oral glucose tolerance tests indicated
elevated fasting blood glucose levels and impaired glucose clearance
capacity in Arfrp1b-cell/ mice, presumably caused by reduced plasma
insulin levels (Figure 1FeI). Morphometric analysis of pancreatic sec-
tions showed a tendency towards bigger islets in Arfrp1b-cell/ mice,
whereas the number of islets per section was unchanged (Appendix
Fig. S1KeM). This might be a compensatory effect in Arfrp1b-cell/
mice to increase the insulin content and to regulate glucose homeostasis
[36].
To clarify whether the reduced plasma insulin levels in Arfrp1b-cell/
mice were the consequence of a reduced insulin secretion, islets from
both Arfrp1flox/flox and Arfrp1b-cell/ mice were isolated and subjected
to perifusion experiments to investigate their capacity for glucose-
stimulated insulin release (Figure 1J). Islets from both genotypes
responded to high-glucose treatment by increasing insulin release,
whereas both the first and second phases of insulin release were
reduced in islets from Arfrp1b-cell/ mice (Figure 1J,K). These find-
ings suggest that ARFRP1 influences insulin secretion from pancreatic
b-cells rather than affecting its synthesis or maturation.
3.2. ARFRP1 interacts with the scaffolding protein GOPC
To clarify the mechanistic basis of ARFRP1 function in insulin secretion,
we screened for interacting proteins. To this end, pulldown experiments
were performed with purified recombinant GST-ARFRP1 and mouse
brain lysates. The brain was used because of greater tissue availability
and significant similarities between the exocytotic machinery in neu-
rons and the islets of Langerhans [37]. Proteins enriched over a GST
control were identified by mass spectrometry (Appendix Fig. S2AeC).
We identified 98 putative interactors in the pulldown and focused on
those proteins with a known Golgi-localization and/or an involvement in
vesicular trafficking. From the resulting 23 gene ontology (GO)-term-
selected interactors, 16 proteins were chosen as prey proteins for
subsequent analysis in a luminescence-based mammalian interactome
(LUMIER) assay (Appendix Fig. S2B, marked by blue dots and Appendix
Fig S2C). V5-tagged candidates fused to firefly luciferase were co-
expressed with protein A-tagged ARFRP1 fused to Renilla luciferase
in HEK293 cells. The efficiency of co-immunoprecipitation was quan-
tified by measuring firefly luciferase activity (Figure 2A). The top hits
consisted of the retromer protein VPS35, the engulfment and cell
motility protein ELMO1, the microtubule-tethering protein 3 (HOOK3),
the exocyst complex components 5 and 7 (EXOC5 and EXOC7), and the
Golgi-associated PDZ and coiled-coil motif-containing protein (GOPC).his is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
www.molecularmetabolism.com
Figure 1: ARFRP1 is required for appropriate insulin secretion in mice. (A) Western blot analysis from isolated islets from ad libitum fed male Arfrp1flox/flox and Arfrp1b-cell/
mice probed with indicated antibodies. (B) Immunostaining of dispersed islet cells from ad libitum fed Arfrp1flox/flox and Arfrp1b-cell/ mice stained for ARFRP1 (white), insulin (red),
and glucagon (green). Nuclei were visualized with DAPI (blue). Scale bar ¼ 40 mm. (C) Blood glucose levels of 13-weeks-old ad libitum fed male Arfrp1flox/flox (n ¼ 12) and
Arfrp1b-cell/ mice (n ¼ 14). (D) Plasma insulin levels of 13 weeks old ad libitum male Arfrp1flox/flox (n ¼ 11) and Arfrp1b-cell/ mice (n ¼ 13). (E) Total pancreatic insulin levels
of ad libitum fed male Arfrp1flox/flox (n ¼ 11) and Arfrp1b-cell/ mice (n ¼ 10). (F) Oral glucose tolerance test in 4h fasted male Arfrp1flox/flox (n ¼ 6) and Arfrp1b-cell/ mice
(n ¼ 9). Blood glucose was measured at indicated time points. Data is shown as mean  SEM (* ¼ p  0.05 2-way ANOVA). (G) Area under the curve of (F). (H) Plasma insulin
levels after oGTT described in (F). (I) Area under the curve of (H). (J) Glucose stimulated insulin secretion from isolated islets of ad libitum fed 12- to 14-week-old male Arfrp1flox/flox
(n ¼ 6) and Arfrp1b-cell/ (n ¼ 7) mice treated with indicated glucose concentrations was measured at indicated time points in perifusion experiments. The first phase is marked
in light gray, and the second phase is marked in dark grey. (K) Calculated area under the curve of first and second phase of glucose-stimulated insulin secretion measured in (J).
Data are presented as mean  SEM, *p  0.05 (unpaired Student’s t-test, Welch’s correction).ELMO1 was excluded from further analysis since it is barely expressed
in b-cells [38], and HOOK3 was excluded due to its described locali-
zation at the cis-Golgi [39]. EXOC7, tested representatively for the
exocyst complex, showed no colocalization with ARFRP1 in Ins1 cells
and was therefore excluded as well (Appendix Fig. S2D).
VPS35 represents the top hit with a 2.8-fold higher luciferase activity
compared to control, while GOPC was enriched 2.3 times over control
(Figure 2A). These two candidates were chosen for further analysis. By
immunostaining of the endogenous proteins in rat insulinoma Ins1
cells, a model for pancreatic b-cells, a Golgi-like pattern for GOPC wasMOLECULAR METABOLISM 45 (2021) 101151  2020 The Authors. Published by Elsevier GmbH. This is an open a
www.molecularmetabolism.comdetermined, supported by colocalization with ARFRP1 (Figure 2B).
VPS35 appeared in vesicular structures, distributed all over the cell,
with an enrichment in proximity to ARFRP1 and GOPC (Figure 2B).
A more precise analysis of the subcellular localization of ARFRP1 and the
putative interacting proteins on the nano-scale was achieved by quan-
titative 3D multicolor SIM (Figure 2C, Appendix Fig. 3A and B, Appendix
animation 1). The quantitative analysis from the SIM images (Figure 2D)
revealed a close association of the identified candidates VPS35 and
GOPC towards ARFRP1, as well as of VPS35 and GOPC towards each
other, which was not due to a random distribution within the cell. Theccess article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/). 5
Figure 2: GOPC is an ARFRP1-interacting protein. (A) Validation of ARFRP1 interacting proteins by LUMIER assay. Red line indicates baseline at 1 after normalization to illustrate
fold change over control. Assay was performed in triplicates. (B) Immunofluorescent pictures of Ins1 cells stained with indicated antibodies. Scale bar represents 20 mm. (C) 3D-
rendering of a ROI (region of interest) that is marked in Appendix Fig. S3B after structured illumination microscopy of Ins1 cells stained with indicated antibodies. White lines outline
the 3-dimensional box containing the immunolabeled proteins. Inner box size ¼ 3.5 * 3.5 mm. (D) Nearest neighbor (NN) distances between surfaces of stained objects were
calculated from SIM images. Corrected NN distances (NN distances after subtracting the random object distribution) are displayed as mean per image. Data is shown as median
with interquartile range from all images (N ¼ 60) of 3 independent experiments with 2 technical duplicates. * ¼ p < 0.05 (two-tailed ManeWhitney test). (E) Schematic of GOPC
expression constructs used for immunoprecipitation assays. L ¼ Leucine zipper. FL ¼ full length GOPC, DPDZ ¼ lacks PDZ domain, DCC ¼ lacks both coiled-coil domains.
Domains are not to scale. F Co-immunoprecipitation assays of Myc-tagged GOPC-constructs described in (E) and GFP-tagged ARFRP1 and GFP alone. Membranes were probed
with indicated antibodies. * ¼ GFP alone in the Myc-blot results from probing the membrane first with GFP antibody, ) ¼ co-precipitated proteins.
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analysis also indicated a closer association between ARFRP1 and GOPC
than between ARFRP1 and VPS35. Based on these results, we focused
on the putative ARFRP1-GOPC interaction in further experiments.
Supplementary video related to this article can be found at https://doi.
org/10.1016/j.molmet.2020.101151
Initially, co-immunoprecipitation experiments were performed.
With the help of the annotated domain structure of GOPC [40],
truncation mutants were generated lacking either the coiled-coil
domains (here DCC) or the PDZ domain (here DPDZ). GFP-
tagged ARFRP1 was co-expressed with Myc-tagged GOPC vari-
ants in HeLa cells and immunoprecipitation was conducted using
GFP-traps. ARFRP1 co-precipitated preferentially with full-length
(FL) GOPC as well as GOPC-DCC (Figure 2F, marked by arrows).
These results point to the PDZ domain of GOPC as interaction
platform for ARFRP1.
3.3. GOPC is required for glucose-stimulated insulin secretion
We next addressed the question of whether the ARFRP1-GOPC inter-
action is of functional relevance for glucose-stimulated insulin secre-
tion. In lysates of isolated islets from Arfrp1b-cell/ mice, GOPC levels
were markedly reduced in comparison to controls, whereas no change
in mRNA levels was observed (Figure 3A and Appendix Fig. S3C).
Immunostainings of dispersed islets isolated from Arfrp1flox/flox and
Arfrp1b-cell/ mice underlined this observation, as signals for GOPC
were only detected in cells expressing ARFRP1 (Figure 3B). These
observations suggest that GOPC stability is impaired in the absence of
Arfrp1. To test whether GOPC is also required for glucose-stimulated
insulin secretion, its expression was suppressed in Min6 cells via
adenoviral delivery of a specific shRNA. Min6 cells are an established
murine model system for b-cells to measure glucose-stimulated in-
sulin secretion. Strikingly, downregulation of Gopc led to significant
reduction of glucose-stimulated insulin secretion (Figure 3C).
To test whether GOPC changes its localization and/or the degree of co-
localization with ARFRP1 upon glucose stimulation, both proteins were
stained in Ins1 cells under basal and glucose-stimulated conditions.
Protein levels of ARFRP1 and GOPC were not altered in any of these
conditions (Appendix Fig. S4A). 3D-SIM confirmed the close associa-
tion of ARFRP1 toward GOPC (Figure 3D,E, Appendix Figure S5,
Appendix animation 2 þ 3) that was not altered after stimulation with
high glucose levels.
Supplementary video related to this article can be found at https://doi.
org/10.1016/j.molmet.2020.101151
Taken together, our data suggest that the Golgi-located scaffolding
protein GOPC has an important role in glucose-stimulated insulin
secretion.
3.4. Deletion of Arfrp1 leads to enhanced degradation of SNAP25
To assign ARFRP1 and GOPC to a specific step in the secretory pro-
cess, the exocytotic machinery was further studied. First, we tested
whether enhanced lysosomal degradation of freshly generated insulin
granules might explain the reduced insulin secretion of Arfrp1b-cell/
mice. Pancreatic sections of Arfrp1flox/flox and Arfrp1b-cell/ mice
were co-stained for insulin and the lysosomal marker LAMP1, without
showing an elevated overlap of insulin with LAMP1 in islets of
Arfrp1b-cell/ mice (Appendix Fig. S6A). Similarly, no differences in
the co-localization of insulin and LAMP1 were detected in Min6 cells
transfected with an Arfrp1-specific shRNA and treated with chloro-
quine or a solvent control (Appendix Fig. S6B). These results indicate
that insulin granules of Arfrp1b-cell/ cells are not degraded to a
higher degree than in controls.MOLECULAR METABOLISM 45 (2021) 101151  2020 The Authors. Published by Elsevier GmbH. This is an open a
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neuronal system [37]. For calcium-dependent insulin and neuro-
transmitter release, the SNARE core proteins Syntaxin1A, Vamp2 and
SNAP25 are required [41,42]. The important role of SNARE proteins
and corresponding factors is underlined by the fact that levels of
SNAP25, VAMP2, and Syntaxin1, for instance, are reduced in islets of
T2D patients [43,44]. VAMP2 localizes to secretory vesicles, while
Syntaxin1A is anchored to the plasma membrane. This localization was
confirmed by immunostaining of both proteins in dispersed islet cells
derived from Arfrp1flox/flox and Arfrp1b-cell/ mice. No difference was
noted between the two genotypes (Appendix Fig. S7A). Total protein
levels of VAMP2 and Syntaxin1A were also not affected (Appendix
Fig. S7B). Analysis of the subcellular localization of SNAP25, howev-
er, revealed reduced protein levels at the plasma membrane in b-cells
lacking Arfrp1 (Figure 4A). Furthermore, SNAP25 protein levels were
also significantly reduced in islets from Arfrp1b-cell/ mice
(Figure 4B,C), whereas mRNA expression levels were unaltered
(Appendix Fig. S4B). This suggests that the changes occur at the
protein level rather than at the gene expression level. A comparable
effect on SNAP25 levels was observed upon downregulation of Gopc in
Min6 cells, an effect which increased over time (Figure 4D). Of note is
that the effect on SNAP25 levels is stronger in Gopc knockdown
conditions compared to Arfrp1 knockdown conditions. This finding was
recapitulated by immunostainings of SNAP25 in Min6 cells after
knockdown (Figure 4E). The protein half-life of SNAP25 is 8e10 h in
PC12 cells [45]. Treatment of Min6 cells with the protein translation
inhibitor cycloheximide revealed a significantly reduced half-life time of
SNAP25 upon downregulation of either Arfrp1 or Gopc when compared
to control cells (Figure 4F). This supports the idea that SNAP25 is more
rapidly degraded in the absence of ARFRP1 and GOPC. The enhanced
degradation of SNAP25 upon knockdown of either Arfrp1 or Gopc could
be blocked by treatment with chloroquine, an inhibitor of lysosomal
maturation (Figure 4G). These data suggest that the ARFRP1-
dependent Golgi-scaffold GOPC is required for the correct localiza-
tion of SNAP25 at the plasma membrane and that knockdown of Arfrp1
or Gopc results in enhanced lysosomal degradation of SNAP25.
3.5. GOPC-based Golgi scaffold controls glucose-stimulated insulin
release via SNAP25
To provide evidence that ARFRP1 and GOPC are directly involved in
glucose-stimulated insulin secretion by regulating plasma membrane
localization and stability of SNAP25, rescue experiments were conducted.
Dispersed islet cells isolated from Arfrp1flox/flox and Arfrp1b-cell/ mice
were treated with adenoviral particles encoding either an empty vector
(Ad-CMV-Null) or a Myc-tagged Arfrp1 variant (Ad-Arfrp1-Myc)
(Figure 5A). Immunolabeling of SNAP25 followed by confocal microscopy
revealed that adenoviral re-expression of Arfrp1 rescued the loss of
SNAP25: In dispersed islet cells from Arfrp1b-cell/mice expressing Ad-
Arfrp1-Myc, an increased plasmamembrane localization of SNAP25 was
observed (Figure 5A, right picture). The same positive effect on SNAP25
localization was observed upon ectopic expression of Gopc in dispersed
islet cells from Arfrp1b-cell/ mice (Figure 5B).
Next, Snap25 was re-expressed in islets from Arfrp1flox/flox and
Arfrp1b-cell/ mice and glucose-stimulated insulin secretion was
examined (Figure 5C). Quantitative measurements of released insulin
recapitulated the reduced insulin secretion capacity of islets from
Arfrp1b-cell/ mice treated with the control virus. Overexpression of
Snap25 in islets from Arfrp1flox/flox mice resulted in slightly reduced
insulin secretion, without reaching significance, which might be
explained by altered stoichiometry of the SNARE complex uponccess article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/). 7
Figure 3: GOPC is required for glucose-stimulated insulin secretion. (A) Western blot analysis of isolated islets from Arfrp1flox/flox and Arfrp1b-cell/ mice probed with
indicated antibodies. (B) Immunofluorescent pictures of dispersed islet cells from Arfrp1flox/flox and Arfrp1b-cell/ mice stained with indicated antibodies. Nuclei were visualized
with DAPI. Scale bar represents 20 mm. (C) Quantification of glucose-stimulated insulin secretion from Min6 cells treated with indicated adenoviruses with a MOI of 50. Data from 3
independent experiments measured in duplicates is shown as mean  SEM. *p < 0.05 (2-way ANOVA). (D) 3D-rendering after structured illumination microscopy of Ins1 cells
under basal (2.8 mM glucose) and stimulated (20 mM glucose) conditions stained for GOPC (green) and ARFRP1 (white). White lines outline the 3-dimensional box containing the
immunolabeled proteins. Inner box size ¼ 3.5 * 3.5 mm. (E) Nearest neighbor (N/N) distances between surfaces of stained objects (GOPC and ARFRP1) were calculated from SIM
images. Corrected NN distances (NN distances after subtracting the random object distribution) are displayed as mean per image. Data is shown as median with interquartile range
from all images (N ¼ 60) of 3 independent experiments with 2 technical duplicates * ¼ p < 0.05 (two-tailed ManeWhitney test).
Original ArticleSNAP25 overexpression. Strikingly, re-expression of Snap25 was
sufficient to restore glucose-stimulated insulin secretion in islets from
Arfrp1b-cell/ mice nearly to the level of controls (Figure 5C). This
indicates that ARFRP1 and GOPC are not required for an appropriate
delivery of SNAP25 from the Golgi to the plasma membrane. In
agreement with this, overexpressed SNAP25 localized to the plasma
membrane in isolated islet cells from Arfrp1flox/flox and Arfrp1b-cell/
mice (Appendix Figure S7C).8 MOLECULAR METABOLISM 45 (2021) 101151  2020 The Authors. Published by Elsevier GmbH. TWe reasoned that lack of ARFRP1 may either enhance the inter-
nalization or impair the recycling of SNAP25, leading to its
enhanced degradation. Since re-expression of Gopc in islet cells
from Arfrp1b-cell/ mice increased SNAP25 levels at the plasma
membrane, glucose-stimulated insulin release was analyzed under
these conditions. As seen for Snap25, overexpression of Gopc
reduced glucose-stimulated insulin release in islet cells from
Arfrp1flox/flox mice (Figure 5D) which again might indicate changes inhis is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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Figure 4: Disruption of ARFRP1 dependent scaffold leads to degradation of SNAP25. (A) Immunofluorescent pictures of dispersed islet cells from Arfrp1flox/flox and
Arfrp1b-cell/ mice stained for SNAP25. Nuclei are visualized by DAPI, scale bar represents 40 mm. (B) Western blot analysis of islets isolated from Arfrp1flox/flox and Arfrp1b-cell/
mice probed with indicated antibodies. (C) Quantification of Western blots shown in (B) of 8 mice per genotype. Relative SNAP25 levels normalized to loading control is shown as
mean  SEM. * ¼ p < 0.05 (unpaired students t-test, Welch’s correction). (D) Western blot analysis of whole cell lysates from Min6 cells treated with indicated adenoviruses at a
MOI of 100 and harvested at indicated time points post-infection. Knockdown efficiency for Arfrp1 is 50% after 48 h, and 60e70% for Gopc after 48 h. Membranes were probed
with indicated antibodies. (E) Immunofluorescent pictures of Min6 cells infected with indicated adenoviruses. Nuclei were visualized with DAPI. Scale bar represents 20 mm. (F)
Quantification of Western blots from whole cell lysates of Min6 cells treated with indicated adenoviruses and cycloheximide (CHX) for indicated time points in 3 independent
experiments. Membranes were probed with indicated antibodies. (G) Western blot analysis of whole cell lysates from Min6 cells treated with indicated adenoviruses and chlo-
roquine (CQ) or solvent control (Co ¼ MiliQ) and harvested 36 h post-infection. Membranes were probed with indicated antibodies.stoichiometry of the SNARE complex. Insulin release from islets
isolated from Arfrp1b-cell/ mice treated with the control virus was
significantly lower compared to islet cells from Arfrp1flox/flox mice.
Upon re-expression of Gopc in islet cells from Arfrp1b-cell/ mice,
however, released insulin levels significantly increased (Figure 5D).
Taken together, these data suggest that deletion of Arfrp1 inMOLECULAR METABOLISM 45 (2021) 101151  2020 The Authors. Published by Elsevier GmbH. This is an open a
www.molecularmetabolism.compancreatic b-cells disrupts a GOPC-based Golgi scaffold, leading to
reduced SNAP25 levels at the plasma membrane, presumably by
enhanced internalization or defective recycling and elevated lyso-
somal degradation of SNAP25 (summarized in Figure 5E). This
might explain the higher blood glucose and lower insulin levels of
Arfrp1b-cell/ mice.ccess article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/). 9
Figure 5: SNAP25 phenotype can be rescued by restoring ARFRP1 dependent scaffold. (A) and (B) Immunofluorescent pictures of dispersed islet cells from Arfrp1flox/flox and
Arfrp1b-cell/ mice treated with indicated adenoviruses at a MOI of 100, fixed and stained for SNAP25 48 h post-infection. Nuclei visualized with DAPI, scale bar represents
10 mm. C Quantification of glucose stimulated insulin secretion from islets isolated from ad libitum fed 11- to 12-week-old Arfrp1flox/flox (n ¼ 4) and Arfrp1b-cell/ (n ¼ 5) mice
infected in duplicates with indicated adenoviruses. Released insulin normalized to residual insulin is shown as fold change compared to 2.8 mM of control. Cells were stimulated
with 20 mM of glucose. Data is shown as mean  SEM. * ¼ p  0.05 (2-way ANOVA). (D) Quantification of glucose stimulated insulin secretion from islets isolated from ad libitum
fed 12-week-old Arfrp1flox/flox (n ¼ 3) and Arfrp1b-cell/ (n ¼ 3) mice infected in duplicates with indicated adenoviruses. Released insulin normalized to residual insulin is shown
as foldchange compared to 2.8 mM of control. Cells were stimulated with 20 mM of glucose. Data is shown as mean  SEM. * ¼ p  0.05 (2-way ANOVA). (E) Graphical
summary. In the absence of ARFRP1, the GOPC scaffold cannot assemble at the TGN. This leads to enhanced degradation of SNAP25. Insulin secretion levels are reduced, and
blood glucose is elevated.
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4. DISCUSSION
This study describes the identification of a newly revealed interaction
of the Golgi protein GOPC with the GTPase ARFRP1 and its impact on
insulin secretion from pancreatic b-cells. ARF proteins are known
regulators of cellular trafficking and signaling events [17,46]. Their
impact on b-cell function is underlined by the described role of ARF6
on maintaining PI(4,5)P2 levels required for regulated exocytosis of
insulin. Our data indicate that a direct or indirect interaction of the ARF-
like protein ARFRP1 and the scaffolding protein GOPC is required for
correct localization of SNAP25 at the plasma membrane of b-cells.
This interaction involves the C-terminal PDZ-domain of GOPC. In the
absence of either ARFRP1 or GOPC, SNAP25 is degraded, and insulin
secretion markedly reduced.
Membrane scaffolds are spatiotemporally regulated assemblies of
multidomain proteins on organellar membranes and important media-
tors of cellular signaling and trafficking events, such as vesicle-
mediated regulated exocytosis. The scaffolding protein GOPC may
represent a platform for proteineprotein interactions, which is facili-
tated by its domain structure, consisting of two N-terminal coiled-coil
domains and a C-terminal PDZ domain. GOPC is described to be a
Rab6a effector protein, since the first coiled-coil domain was found to
interact with Rab6a [47]. The second coiled-coil domain interacts with
Syntaxin6 and the GTPase Tc10 and is required for the Golgi localization
and suggested to mediate a dimerization of the protein [40,48]. The PDZ
domain interacts with C-termini of different membrane proteins, such as
the cystic fibrosis transmembrane regulator, glutamate receptor 2, and
CD46-Cyt1 [49e51]. Furthermore, GOPC was shown to be involved in
postendocytic trafficking as it protects the b1-adrenergic receptor from
lysosomal degradation [52]. We identified the C-terminus of the protein
that includes the PDZ domain of GOPC as a region to which ARFRP1
might bind. Whether this is a direct interaction needs to be further
proven by biochemical assays. PDZ domains are described to bind to the
C-terminal residues of target proteins [53]. ARFRP1, however, lacks a
classical PDZ binding motif in its C-terminal region, which may indicate
an indirect interaction between the two proteins. A sequence upstream
of the PDZ domain of GOPC was shown to be required for the interaction
with Stargazin, a regulator of AMPA-selective glutamate receptors [54].
This particular sequence is however not included in our DCC construct
that contains only the PDZ domain.
Rising blood glucose levels stimulate insulin release from pancreatic
b-cells, a well-known example for regulated membrane trafficking and
exocytosis. Intracellular trafficking routes are often shared by different
transporters or cargos. Therefore, regulatory mechanisms are required
for every target to reach its correct destination, and the secretory
machinery needs to quickly adapt to various extracellular stimuli. The
here-identified new ARFRP1-interacting protein GOPC is required for
glucose-stimulated insulin release. Disruption of this interaction leads
to reduced GOPC protein levels and affects glucose homeostasis in
mice, as shown by elevated blood glucose levels, impaired glucose
tolerance, and reduced insulin secretion capacity in Arfrp1b-cell/
mice. Despite this impaired insulin secretion, Arfrp1b-cell/ mice did
not become diabetic. However, we observed slightly enlarged islets in
Arfrp1b-cell/ mice, which might be a compensatory effect to guar-
antee an overall lower but still sufficient insulin release in order to
prevent severe hyperglycemia and the development of diabetes. This
compensatory capacity can be linked to the genetic background of the
knockout animals (C57BL/6), that do not become diabetic because it
induces b-cell proliferation and thereby increases insulin secretion
when blood glucose levels rise [33,36]. Insulin is well known to control
food intake and satiety [55,56]. Since plasma insulin levels areMOLECULAR METABOLISM 45 (2021) 101151  2020 The Authors. Published by Elsevier GmbH. This is an open a
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intake leading to the observed elevated fat mass.
The fact that deletion of Arfrp1 reduced glucose-stimulated insulin
secretion but not total pancreatic insulin levels or the maturation of
insulin indicates a secretory defect. Since both the first and second
phase of insulin secretion were reduced in islets from Arfrp1b-cell/
mice, it can be concluded that the ARFRP1-GOPC interaction is required
for the fusion process of insulin-containing granules with the plasma
membrane. In fact, suppression of both Arfrp1 or Gopc in Min6 cells
resulted in lower levels of SNAP25 (Figure 4D,E), a protein which is
essential for fusion of vesicles with the plasma membrane in order to
release their cargo [57]. Our data indicate that both ARFRP1 and GOPC
are needed for the correct localization of SNAP25 at the plasma
membrane. Since overexpressed SNAP25 in Arfrp1b-cell/ islets lo-
calizes to the plasma membrane, we can exclude that ARFRP1 and
GOPC regulate targeting of newly synthesized SNAP25 to the plasma
membrane. In their absence, SNAP25 may be internalized faster or not
sorted to the appropriate recycling vesicles and thereby degraded,
resulting in reduced protein levels and a significantly reduced protein
half-life time. In fact, the degradation of SNAP25 was blocked by
treating cells with chloroquine, suggesting that SNAP25 is degraded via
the lysosome in the absence of ARFRP1 or GOPC. Accordingly, ARFRP1
was described to be involved in retrograde trafficking from endosomal
structures to the TGN [22,58]. SNAP25 located at the plasma mem-
brane was described to be internalized via dynamin-independent
endocytosis and to be recycled in an ARF6-dependent manner. In the
same study, the SNAP25-interacting SNARE protein Syntaxin1A, which
is also relevant for insulin release from pancreatic b-cells, was shown
not to be co-internalized with SNAP25 [59]. This agrees with our ob-
servations that SNAP25 is the only SNARE protein of the VAMP2-STX1A-
SNAP25 complex affected by Arfrp1 and Gopc knockdown (Appendix
Fig. S7A þ B). The fact that only SNAP25 but not VAMP2 and STX1A
is degraded after suppression of Arfrp1 and Gopc1 might indicate that
SNAP25 can act independently of this complex. A role for SNAP25 in
endosome fusion was suggested but not further investigated [60]. We
observed earlier that a related SNARE protein, SNAP23, was missorted
in adipocytes from adipose tissue-specific Arfrp1 knockout mice
without affecting total protein levels [19]. We did not detect an inter-
action of ARFRP1 or GOPC with SNAP25 by co-immunoprecipitation
assays (Appendix Fig. S8). Thus, it remains to be clarified whether
and how ARFRP1 and GOPC mediate SNAP25 sorting. A b-cell-specific
Snap25 knockout mouse has not been described so far. However, a
mouse carrying a mutation in the Syntaxin1 binding site of SNAP25
shows impaired granule exocytosis in pancreatic b-cells along with
elevated blood glucose levels [61], supporting the important role of
SNAP25-dependent steps for insulin secretion. Further support is given
by our rescue experiments showing that re-expression of Snap25 in
islets of Arfrp1b-cell/ mice is sufficient to restore the capacity of
glucose-stimulated insulin release. Comparable effects on restoring
GSIS levels were observed when re-expressing either Syntaxin1a or
Snap25 in islets of GK rats, a lean model for T2D that possess reduced
protein levels of Syntaxin1A and SNAP25 [62].
In summary, ARFRP1 acts at the TGN by recruiting effector proteins to
regulate endosomal recycling processes, which affect hormone
release from metabolic active tissues, as shown earlier for adiponectin
from adipocytes and IGF1 release from hepatocytes [20,27]. From the
data presented in this study, we conclude that both ARFRP1 and GOPC
are involved in the correct localization of SNAP25 at the plasma
membrane and thereby in glucose-stimulated secretion of insulin from
pancreatic b-cells. This describes a hitherto unrecognized pathway
required for insulin secretion at the level of trans-Golgi sorting.ccess article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/). 11
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